Clinical Outcomes Used in Clinical Pharmacy Intervention Studies in Secondary Care

Overview

Journal Pharmacy (Basel)

Date 2017 Oct 4

PMID 28970440

Citations 6

Authors

Lene Juel Kjeldsen

Charlotte Olesen

Merete Kjaer Hansen

Trine Rune Hogh Nielsen

Affiliations

Soon will be listed here.

Abstract

The objective was to investigate type, frequency and result of clinical outcomes used in studies to assess the effect of clinical pharmacy interventions in inpatient care. The literature search using Pubmed.gov was performed for the period up to 2013 using the search phrases: "Intervention(s)" and "pharmacist(s)" and "controlled" and "outcome(s)" or "effect(s)". Primary research studies in English of controlled, clinical pharmacy intervention studies, including outcome evaluation, were selected. Titles, abstracts and full-text papers were assessed individually by two reviewers, and inclusion was determined by consensus. In total, 37 publications were included in the review. The publications presented similar intervention elements but differed in study design. A large variety of outcome measures (135) had been used to evaluate the effect of the interventions; most frequently clinical measures/assessments by physician and health care service use. No apparent pattern was established among primary outcome measures with significant effect in favour of the intervention, but positive effect was most frequently related to studies that included power calculations and sufficient inclusion of patients (73% vs. 25%). This review emphasizes the importance of considering the relevance of outcomes selected to assess clinical pharmacy interventions and the importance of conducting a proper power calculation.

Citing Articles

Clinical pharmacy key performance indicators for hospital inpatient setting: a systematic review.

Magedanz L, Silva H, Galato D, Fernandez-Llimos F Int J Clin Pharm. 2024; 46(3):602-613.

PMID: 38570475 PMC: 11133179. DOI: 10.1007/s11096-024-01717-x.

The effect of structured medication review followed by face-to-face feedback to prescribers on adverse drug events recognition and prevention in older inpatients - a multicenter interrupted time series study.

Klopotowska J, Kuks P, Wierenga P, Stuijt C, Arisz L, Dijkgraaf M BMC Geriatr. 2022; 22(1):505.

PMID: 35715742 PMC: 9206349. DOI: 10.1186/s12877-022-03118-z.

Exploration of Symptom Scale as an Outcome for Deprescribing: A Medication Review Study in Nursing Homes.

Dalin D, Frandsen S, Madsen G, Vermehren C Pharmaceuticals (Basel). 2022; 15(5).

PMID: 35631333 PMC: 9143953. DOI: 10.3390/ph15050505.

Rates and correlates of pharmacotherapy-related problems among psychiatric inpatients: a representative Danish study.

Kibsdal K, Andersen S, Gazerani P, Plet H Ther Adv Psychopharmacol. 2020; 10:2045125320957120.

PMID: 32974001 PMC: 7491228. DOI: 10.1177/2045125320957120.

Role and impact of pharmacists in Spain: a scoping review.

Saavedra-Mitjans M, Ferrand E, Garin N, Bussieres J Int J Clin Pharm. 2018; 40(6):1430-1442.

PMID: 30367376 DOI: 10.1007/s11096-018-0740-7.

References

Lai P, Chua S, Chew Y, Chan S . Effects of pharmaceutical care on adherence and persistence to bisphosphonates in postmenopausal osteoporotic women. J Clin Pharm Ther. 2011; 36(5):557-67. DOI: 10.1111/j.1365-2710.2010.01210.x. View

Mekonnen A, McLachlan A, Brien J . Effectiveness of pharmacist-led medication reconciliation programmes on clinical outcomes at hospital transitions: a systematic review and meta-analysis. BMJ Open. 2016; 6(2):e010003. PMC: 4769405. DOI: 10.1136/bmjopen-2015-010003. View

Jacobs M, Sherry P, Taylor L, Amato M, Tataronis G, Cushing G . Pharmacist Assisted Medication Program Enhancing the Regulation of Diabetes (PAMPERED) study. J Am Pharm Assoc (2003). 2012; 52(5):613-21. DOI: 10.1331/JAPhA.2012.10183. View

Kaboli P, Hoth A, McClimon B, Schnipper J . Clinical pharmacists and inpatient medical care: a systematic review. Arch Intern Med. 2006; 166(9):955-64. DOI: 10.1001/archinte.166.9.955. View

Hellstrom L, Hoglund P, Bondesson A, Petersson G, Eriksson T . Clinical implementation of systematic medication reconciliation and review as part of the Lund Integrated Medicines Management model--impact on all-cause emergency department revisits. J Clin Pharm Ther. 2012; 37(6):686-92. DOI: 10.1111/jcpt.12001. View

Jackson S, Peterson G, Vial J, Jupe D . Improving the outcomes of anticoagulation: an evaluation of home follow-up of warfarin initiation. J Intern Med. 2004; 256(2):137-44. DOI: 10.1111/j.1365-2796.2004.01352.x. View

Bladh L, Ottosson E, Karlsson J, Klintberg L, Wallerstedt S . Effects of a clinical pharmacist service on health-related quality of life and prescribing of drugs: a randomised controlled trial. BMJ Qual Saf. 2011; 20(9):738-46. DOI: 10.1136/bmjqs.2009.039693. View

Jarab A, Alqudah S, Mukattash T, Shattat G, Al-Qirim T . Randomized controlled trial of clinical pharmacy management of patients with type 2 diabetes in an outpatient diabetes clinic in Jordan. J Manag Care Pharm. 2012; 18(7):516-26. PMC: 10437536. DOI: 10.18553/jmcp.2012.18.7.516. View

Magid D, Ho P, Olson K, Brand D, Welch L, Snow K . A multimodal blood pressure control intervention in 3 healthcare systems. Am J Manag Care. 2011; 17(4):e96-103. View

10.

Albsoul-Younes A, Hammad E, Yasein N, Tahaineh L . Pharmacist-physician collaboration improves blood pressure control. Saudi Med J. 2011; 32(3):288-92. View

11.

Williamson P, Altman D, Blazeby J, Clarke M, Devane D, Gargon E . Developing core outcome sets for clinical trials: issues to consider. Trials. 2012; 13:132. PMC: 3472231. DOI: 10.1186/1745-6215-13-132. View

12.

McCoy A, Cox Z, Neal E, Waitman L, Peterson N, Bhave G . Real-time pharmacy surveillance and clinical decision support to reduce adverse drug events in acute kidney injury: a randomized, controlled trial. Appl Clin Inform. 2012; 3(2):221-238. PMC: 3377180. DOI: 10.4338/ACI-2012-03-RA-0009. View

13.

Crotty M, Rowett D, Spurling L, Giles L, Phillips P . Does the addition of a pharmacist transition coordinator improve evidence-based medication management and health outcomes in older adults moving from the hospital to a long-term care facility? Results of a randomized, controlled trial. Am J Geriatr Pharmacother. 2005; 2(4):257-64. DOI: 10.1016/j.amjopharm.2005.01.001. View

14.

Kjeldsen L, Nielsen T, Olesen C . The challenges of outcome research. Int J Clin Pharm. 2016; 38(3):705-8. DOI: 10.1007/s11096-016-0293-6. View

15.

Lim W, Low H, Chan S, Chen H, Ding Y, Tan T . Impact of a pharmacist consult clinic on a hospital-based geriatric outpatient clinic in Singapore. Ann Acad Med Singap. 2004; 33(2):220-7. View

16.

Wong I . Randomised controlled trials (RCTs) to evaluate complex healthcare interventions--a case study. Pharm World Sci. 2004; 26(5):247-52. DOI: 10.1023/b:phar.0000042920.34663.04. View

17.

Kripalani S, Roumie C, Dalal A, Cawthon C, Businger A, Eden S . Effect of a pharmacist intervention on clinically important medication errors after hospital discharge: a randomized trial. Ann Intern Med. 2012; 157(1):1-10. PMC: 3575734. DOI: 10.7326/0003-4819-157-1-201207030-00003. View

18.

Lee V, Fan C, Li A, Chau A . Clinical impact of a pharmacist-physician co-managed programme on hyperlipidaemia management in Hong Kong. J Clin Pharm Ther. 2009; 34(4):407-14. DOI: 10.1111/j.1365-2710.2009.01024.x. View

19.

Jarab A, Alqudah S, Khdour M, Shamssain M, Mukattash T . Impact of pharmaceutical care on health outcomes in patients with COPD. Int J Clin Pharm. 2011; 34(1):53-62. DOI: 10.1007/s11096-011-9585-z. View

20.

Gillespie U, Alassaad A, Henrohn D, Garmo H, Hammarlund-Udenaes M, Toss H . A comprehensive pharmacist intervention to reduce morbidity in patients 80 years or older: a randomized controlled trial. Arch Intern Med. 2009; 169(9):894-900. DOI: 10.1001/archinternmed.2009.71. View